Zum Inhalt springen

Roche Partner

Roche ist heute für mehr als 80 Unternehmen weltweit ein geschätzter Partner. Wir sind uns bewusst, dass kein Unternehmen das Monopol auf Innovation besitzt. Es ist unsere Aufgabe, die entscheidenden Fortschritte in der modernen Medizin zu machen - wo immer diese zu finden sind - und diese den Patienten so schnell als möglich zur Verfügung zu stellen. Durch unsere Allianzen haben wir gelernt, dass dabei der Erfolg das eigentliche Abkommen weit übersteigt. Nur langfristige Partnerschaften, in denen die Zusammenarbeit erfolgreich umgesetzt werden kann, bringe für beide Seiten echte Gewinne.

Plexxikon: potential for personalised medicine

Differentiated medicine

  • First-in-class oral medicine

Strategic fit

  • Oncology
  • Validated discovery platform for novel drugs; potential to expand collaboration
  • Potential for personalised medicine with parallel diagnostics collaboration

Cultural fit

  • Experienced management team
  • Excellent collaboration while evaluating
  • Open discussion of development strategy

"With Roche we have a seat at the development table - that is very important to us."

Kathy Glaub, President, Plexxikon
www.plexxikon.com

Intermune: commitment to HCV

Strategic fit

  • Shared therapeutic focus: HCV
  • InterMune's HCV protease inhibitor programme complements Roche's pipeline and expertise in virology

Cultural fit

  • Shared motivations
  • Aligned expectations
  • InterMune has co-development and co-commercialisation option with 50:50 profit share in the USA

"We believe this partnership will help accelerate the development of ITMN-191 while allowing InterMune to share in the substantial value creation opportunity."

Dan Welch, President and CEO, InterMune
www.intermune.com

Synosia: innovative asset management

  • Roche offers clinical phase CNS compounds in new development partnership
  • Synosia uses small, smart clinical trials to fast-track proof-of-concept in new CNS indications
  • New development model receives substantial financial backing from venture capitalists

"Unlike the traditional licensing model, this deal shows how venture capitalists and pharma can build partnerships with biotech."

Brad Bolzon, Managing Director, Versant Ventures
www.synosia.com

Actelion: parallel development

  • One specific target, multiple indications developed in parallel
  • Actelion funds development up to end of phase II
  • Subsequent development and commercialisation costs shared equally
  • Co-commercialisation and equal profit share on products arising from collaboration

"I am very proud about our collaboration with Roche, an excellent partner to develop and promote multiple indications in parallel."

Jean-Paul Clozel, Managing Director and CEO, Actelion
www.actelion.com

Evotec: An evolving relationship

  • From service agreement to collaboration
  • Extensions of existing agreements
  • Creation of new collaborations

Multiple dimensions

  • Two-way licensing
  • Service agreements
  • Asset management
  • Joint drug discovery

Trust built on experience

  • Encouraged by success
  • Understanding ensures smooth resolution of issues
  • Rapid implementation of new deals

"We have been working with Roche for many years in an atmosphere of mutual respect."

John Kemp, Chief R&D Officer, Evotec
www.evotec.com

Morphosys: an expanding collaboration

  • Reliable partner
  • Innovative technologies for accelerated drug discovery and target characterisation
  • In vitro generation of therapeutic antibodies

First collaboration

  • Sept 2000
  • Alzheimer's disease
  • Milestone entry to PhI achieved Jan 2006

Second collaboration

  • March 2006
  • Encouraged by success
  • Explore another indication: oncology
  • Two new programmes

"Expanding our existing partnerships is a high priority to us."

Simon Moroney, CEO, MorphoSys
www.morphosys.com

Kontakt

Roche Partnering
Tel. +41 61 688 4700
E-Mail

Project Coordinator Genentech
Fax (650) 225-3009
busdev@gene.com

Diagnostics Collaborations
Tel. +41 61 687 2516  (Switzerland)
Tel. + 1 925 730 8569 (USA)
Dia.partnering @roche.com

Suchen Sie einen speziellen Kontakt?

Related Links

Downloads